Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report released on Thursday morning, Benzinga reports. HC Wainwright currently has a $6.00 target price on the biotechnology company’s stock. Other research analysts have also recently issued reports about the stock. TheStreet cut shares of Cidara Therapeutics from […]
HC Wainwright reaffirmed their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report report published on Thursday, Benzinga reports. HC Wainwright currently has a $6.00 price objective on the biotechnology company’s stock. A number of other research firms have also commented on CDTX. TheStreet lowered shares of Cidara Therapeutics […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Monday. A number of other research analysts also recently commented on CDTX. Cantor Fitzgerald restated an “overweight” rating and issued a $5.00 target price on shares of Cidara […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. Other analysts have also issued research reports about the company. TheStreet lowered Cidara Therapeutics from a “c” rating to a “d+” […]
HC Wainwright reiterated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research note issued to investors on Monday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Cidara Therapeutics’ Q1 2024 earnings at ($0.07) EPS, Q2 2024 earnings […]